U.S. Residential REITs Stock News

If you are wondering whether Watts Water Technologies at around US$296 per share is still fairly priced or starting to look stretched, you are not alone. The stock is up 6.3% year to date and 22.3% over the last year, although it has slipped 1.3% over the past week and 2.1% over the past month, which may have some holders reassessing the balance of risk and reward. Recent news coverage has focused on Watts Water Technologies in the context of broader interest in industrial and infrastructure...

Multiple federal securities class action lawsuits have been filed against POET Technologies alleging misstatements regarding its U.S. PFIC tax status. The suits claim the company failed to disclose tax risks for U.S. investors and that confidentiality breaches by an executive led to the cancellation of a major order. Plaintiffs argue these issues harmed POET Technologies' business prospects and exposed shareholders to material legal and financial risks. For investors watching POET...

On May 15, 2026, Investor Advocates for Social Justice filed an exempt solicitation with the SEC supporting a shareholder proposal from the Congregation of the Sisters of Saint Joseph of Peace that asks Palantir Technologies to publish a Human Rights Impact Assessment and urges fellow investors to back it at the 2026 annual meeting. This push for a formal review of human rights impacts highlights growing investor scrutiny of how Palantir’s AI and data platforms are used by government...

RH Milan opening puts international expansion in focus RH (RH) is drawing fresh attention after Chairman and CEO Gary Friedman addressed the city of Milan in a public letter tied to the opening of RH Milan, The Gallery on Corso Venezia. The seven level space, described as a combination of furniture, design, food and wine, marks a new European presence that could influence how investors think about RH's brand reach and long term opportunities outside North America. See our latest analysis for...

LTC Properties, Inc. reported first-quarter 2026 results on May 6, showing sales of US$75.92 million and revenue of US$95.41 million, with net income of US$23.59 million and diluted EPS of US$0.48 from continuing operations. Alongside this earnings release, LTC’s upcoming conference appearances signal management’s focus on communicating how its expanded seniors housing portfolio is translating into higher reported revenue and earnings. We’ll now examine how LTC’s strong first-quarter revenue...

Rockwell Automation (ROK) has drawn fresh investor attention after recent share price moves and updated return figures, prompting a closer look at how the industrial automation company’s fundamentals line up with its current valuation. See our latest analysis for Rockwell Automation. Recent trading has been choppy, with the share price down 3.22% over the last day and 7.21% over the past week. However, a 1-year total shareholder return of 38.58% and 5-year total shareholder return of 75.74%...

In recent weeks, General Dynamics reported Q1 2026 results showing revenue growth across all four segments, with Marine Systems leading operating earnings growth and a consolidated book-to-bill ratio of 2-to-1 on US$26.60 billion of orders. The company also announced new defense wins and partnerships, including a US$229.65 million Stryker vehicle contract and a collaboration with Kodiak AI on autonomous ground systems, underscoring demand for both traditional and emerging platforms. Now we...

Wondering if Vertex Pharmaceuticals at US$434.31 is offering good value right now, or if the easy money has already been made. The stock is down 3.1% over the last week, 1.6% over the past month and 3.9% year to date, even though the 3 year and 5 year returns sit at 30.2% and 108.0% respectively. These moves are playing out against a backdrop of ongoing interest in large biotech companies, as investors continue to weigh long term product pipelines against current pricing. While day to day...

Recent share performance and business snapshot Marriott Vacations Worldwide (VAC) stock has been under pressure recently, with the price at US$70.26 after declines of about 3% over the past week and 6% over the past month. Over the past 3 months and year to date, however, the stock is higher by about 19% and 19% respectively, while the 1 year total return is about 5%, set against weaker 3 year and 5 year records. The company reports annual revenue of about US$3.33b, with revenue growth of...

Air Products and Chemicals (APD) stock has been drawing attention after recent trading moves, with investors weighing its returns over the past year against current valuation signals and the company’s role across industrial and specialty gases. See our latest analysis for Air Products and Chemicals. With the share price at $291.77, recent trading has been a bit softer in the very short term, with the 7 day share price return down 3.9%. However, the year to date share price return of 16.49%...

Nuvalent (NUVL) has drawn investor attention after recent share price moves, with the stock last closing at $101. With no revenue yet, the clinical-stage biopharma story rests on pipeline progress and ongoing trial outcomes. See our latest analysis for Nuvalent. Recent trading has been choppy, with the 1-day share price return of 1.10% contrasting with a 30-day share price decline of 6.14%. However, the 1-year total shareholder return of 33.10% and 3-year total shareholder return of about...

Nektar Therapeutics (NasdaqCM:NKTR) has appointed Linda Rubinstein as Chief Financial Officer. Rubinstein succeeds retiring CFO Sandra Gardiner and brings experience in large M&A and capital markets transactions. Nektar Therapeutics is drawing fresh attention with this leadership change, coming after a very large 1 year share price gain and a year to date return of 55.6%. The stock last closed at $67.58, even after declining 13.8% over the past week and 20.4% over the past month. For...

Wondering whether Halliburton at around US$42.98 is still priced for opportunity or already reflecting a lot of optimism, this article focuses squarely on what you are getting for the price you pay. The stock has shown strong recent moves, with returns of 3.1% over 7 days, 15.7% over 30 days, 45.2% year to date and 115.6% over 1 year, so valuation is front of mind for many investors. Recent coverage around Halliburton has centered on its role in the energy sector and investor interest in...

Blue Owl Capital (NYSE:OWL) appointed Deva Mishra as Head of Blue Owl Insurance Solutions, expanding its focus on insurance related investment capabilities. The company also broadened its GP Strategic Capital business with a multi layered liquidity platform designed to provide additional liquidity options for limited partners. For investors following NYSE:OWL, these moves sit at the intersection of private markets and insurance capital, two areas that have attracted sustained attention from...

Considering whether Elanco Animal Health at around US$19.80 is still offering value, or if the easy gains are already behind it. The stock is down 7.6% over the past week, 16.4% over the past month and 12.1% year to date, even though it is up 51.4% over the last year and 129.7% over three years, while the five year return sits at a decline of 44.2%. These mixed returns arrive as investors continue to reassess the outlook for animal health companies and their ability to sustain growth in...

ZoomInfo Technologies (GTM) cut its full year 2026 revenue outlook after reporting first quarter results that showed sales of US$310.2 million and net income of US$29.3 million, prompting closer attention to the stock. See our latest analysis for ZoomInfo Technologies. The share price has been under pressure, with a 1 day move down 2.81% and a 30 day share price return down 38.65%. The 1 year total shareholder return is down 60.72%, and longer term losses are steeper. This suggests momentum...

Seagate Technology Holdings (NasdaqGS:STX) highlighted significant production capacity constraints at a major investor conference. The CEO indicated the company is prioritizing technology advancement and manufacturing efficiency instead of rapid factory expansion. The comments coincided with sector wide selling in hard drive and memory stocks and renewed debate about long term AI supply planning. For investors watching Seagate Technology Holdings at a share price of $733.35, the new...

AXT recently reported stronger first‑quarter results, with revenue growth and a much smaller net loss driven by heightened demand for its indium phosphide substrates used in AI data centers, and completed a US$632.5 million capital raise to expand manufacturing capacity and fund R&D. This combination of improving earnings metrics, a large AI‑linked order backlog and significant new funding underscores how central AXT’s materials have become to current data center and AI infrastructure...

Kratos Defense & Security Solutions: Recent Stock Performance Context Kratos Defense & Security Solutions (KTOS) has seen its stock retreat recently, with the price down about 1% over the past day, 7% over the past week, and 25% over the past month. Over the past 3 months, the stock has fallen roughly 45%, while year to date it is down about 33%. Even so, the 1 year total return sits near 50%, and the 3 year total return is a little under 3x. See our latest analysis for Kratos Defense &...

If you are wondering whether Datadog at US$215.15 is priced for perfection or still offers value, the next sections will walk through what the current market price might be implying. The stock has logged returns of 7.6% over the past week, 69.9% over the past month, 60.8% year to date and 85.0% over the last year, which naturally raises questions about how much of the story is already reflected in the share price. Recent attention on Datadog has focused on its role in cloud monitoring and...

In May 2026, Halozyme Therapeutics, Inc. reported first-quarter 2026 results showing revenue of US$376.71 million and net income of US$150.05 million, reaffirmed its 2026 revenue guidance of US$1.71 billion to US$1.81 billion, announced a new share repurchase authorization of up to US$1.00 billion through 2028, and confirmed completion of a prior buyback program. Earlier that month, GSK announced a global collaboration and license agreement to use Halozyme’s ENHANZE technology across...

Webull (BULL) has been drawing attention after recent trading in its stock. This is prompting investors to look more closely at how its digital brokerage business, revenue profile, and current valuation metrics fit into their portfolios. See our latest analysis for Webull. Recent trading has been mixed, with the share price slipping about 1% over the last day but still up roughly 17% over 90 days. However, the 1 year total shareholder return remains down sharply at about 43%, suggesting near...

Why Firefly Aerospace (FLY) is on investors’ radar Firefly Aerospace (FLY) has drawn fresh attention after recent share price swings, with the stock down 3.1% on the day but up 8.3% over the past week and 79.2% year to date. See our latest analysis for Firefly Aerospace. For context, Firefly Aerospace’s recent pullback comes after a sharp build up in momentum, with the 90 day share price return of 98.3% and year to date share price return of 79.2% pointing to a rapid rerating as investors...

Thermon Group Holdings (THR) just wrapped FY 2026 with fourth quarter revenue of US$148.3 million and basic EPS of US$0.08 on net income of US$2.7 million, while trailing 12 month figures show total revenue of US$536.3 million and basic EPS of US$1.37 backed by net income of US$44.6 million. Over recent periods, the company has seen quarterly revenue range from US$108.9 million to US$148.3 million with basic EPS between US$0.26 and US$0.56. Trailing 12 month basic EPS has moved between...